Qube Research & Technologies (QRT)’s Affimed AFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-254
Closed -$1.59K 4418
2023
Q4
$1.59K Sell
254
-1,770
-87% -$7.34K ﹤0.01% 3834
2023
Q3
$9.67K Sell
2,024
-19,522
-91% -$108K ﹤0.01% 3326
2023
Q2
$129K Buy
+21,546
New +$173K ﹤0.01% 1898
2022
Q4
Sell
-3,592
Closed -$74K 2417
2022
Q3
$74K Buy
3,592
+1,997
+125% +$55.5K ﹤0.01% 2056
2022
Q2
$44K Buy
+1,595
New +$54.6K ﹤0.01% 2146
2021
Q4
Sell
-6,427
Closed -$397K 2480
2021
Q3
$397K Sell
6,427
-3,149
-33% -$207K 0.01% 1343
2021
Q2
$814K Buy
9,576
+4,128
+76% +$377K 0.01% 1033
2021
Q1
$431K Buy
5,448
+1,930
+55% +$125K 0.01% 1264
2020
Q4
$205K Buy
+3,518
New +$166K ﹤0.01% 1523

Other funds holding AFMD

Qube Research & Technologies (QRT)'s AFMD Position: Q1 2024 in Review

Qube Research & Technologies (QRT) sold out of Affimed (AFMD) in Q1 2024, closing a stake of 254 shares — an estimated $1.59K sold.

Qube Research & Technologies (QRT) first reported a position in AFMD in Q4 2020 and held it in 9 quarters. The position peaked at $814K in Q2 2021. 46 funds tracked by Wall St. Rank hold AFMD as of Q1 2024.

  • Qube Research & Technologies (QRT) reported no remaining Affimed position as of Q1 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 254 Affimed shares in Q1 2024, an estimated $1.59K.
  • Qube Research & Technologies (QRT) first reported a position in Affimed in Q4 2020 and held it in 9 quarters.
  • Qube Research & Technologies (QRT)'s Affimed position peaked at $814K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Affimed as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.